One of most relevant advances in this field has been the identification of IFN-induced protein 44-like (IFI44L) promoter methylation in peripheral blood cells as a biomarker with high sensitivity and specificity for diagnosis of SLE superior to that of other available tests (78). Here, IFI44L is linked to systemic lupus erythematosus.